Vanessa Saliba1, Natasha Azzopardi Muscat2, Mairi Vella3, Simon Attard Montalto4, Charlene Fenech5, Martin McKee6, Cécile Knai7. 1. Research fellow, European Centre on the Health of Societies in Transition, London School of Hygiene and Tropical Medicine, London, United Kingdom vanessa.saliba@lshtm.ac.uk. 2. Lecturer, Health Services Management Department, Faculty of Health Sciences, University of Malta, Msida, Malta Faculty of Health, Medicine and Life Sciences, CAPHRI School of Public Health and Primary Care, Department of International Health Maastricht University. 3. Higher Specialist Trainee, Department of Paediatrics, Mater Dei Hospital, Msida, Malta. 4. Head Academic Department of Paediatrics, The Medical School, University of Malta, Msida, Malta. 5. Manager, Treatment Abroad, Ministry of Health, Elderly and Community Care, Valletta, Malta. 6. Professor of European Public Health, European Centre on the Health of Societies in Transition, London School of Hygiene and Tropical Medicine, London, United Kingdom. 7. Lecturer, European Centre on the Health of Societies in Transition, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Abstract
OBJECTIVE: The Malta-UK cross-border health care collaboration gives Maltese patients access to highly specialized care that is not available locally. Our aim was to identify the issues that arise in cross-border specialized care for rare childhood diseases. METHODS: We conducted 31 semi-structured face-to-face interviews with policy makers, consultant pediatricians from Mater Dei Hospital in Malta, the Royal Marsden Hospital and Great Ormond Street Hospital in England and the parents of a random sample of children referred for treatment abroad in 2011. We conducted qualitative thematic analysis of the data. RESULTS: Respondents viewed the collaboration as successful in providing timely access to high quality specialist care. Four factors facilitated implementation: long established personal relationships; communication and data sharing; shared care approach; and well established support systems. The key challenges are logistical, financial, communication and cultural and psychological. CONCLUSION: Cross-border care pathways can successfully support access to high quality specialized care that is acceptable to health professionals and patients.
OBJECTIVE: The Malta-UK cross-border health care collaboration gives Maltese patients access to highly specialized care that is not available locally. Our aim was to identify the issues that arise in cross-border specialized care for rare childhood diseases. METHODS: We conducted 31 semi-structured face-to-face interviews with policy makers, consultant pediatricians from Mater Dei Hospital in Malta, the Royal Marsden Hospital and Great Ormond Street Hospital in England and the parents of a random sample of children referred for treatment abroad in 2011. We conducted qualitative thematic analysis of the data. RESULTS: Respondents viewed the collaboration as successful in providing timely access to high quality specialist care. Four factors facilitated implementation: long established personal relationships; communication and data sharing; shared care approach; and well established support systems. The key challenges are logistical, financial, communication and cultural and psychological. CONCLUSION: Cross-border care pathways can successfully support access to high quality specialized care that is acceptable to health professionals and patients.